PARD6A and colorectal adenocarcinoma: Since our compounds induced Par-6 modulation we decided to test if myricetin (the-110) could increase epithelial barrier strength using human colorectal adenocarcinoma cell line (Caco-2)—a widely used model for permeability assays.